Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Oncogene
|
August 15, 2020
BRAF<sup>V600E</sup> drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Nadine Reischmann, Geoffroy Andrieux, Ricarda Griffin, et al.
Oncotarget
|
January 23, 2016
Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
Raphaela Fritsche-Guenther, Franziska Witzel, Stefan Kempa, et al.
European Journal of Immunology
|
December 8, 2004
Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors
Susana Minguet, Michael Huber, Lisa Rosenkranz, et al.
Molecular Biology of the Cell
|
December 18, 2012
PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway
Christine Kienzle, Stephan A Eisler, Julien Villeneuve, et al.
International Journal of Cancer
|
March 15, 2026
Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics
Viktoria Zieger, Ellen Woehr, Jasmin Traichel, et al.
Oncotarget
|
May 15, 2015
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
Kerstin Mock, Bogdan-Tiberius Preca, Tilman Brummer, et al.
The FEBS Journal
|
June 4, 2020
Functional coupling of presequence processing and degradation in human mitochondria
Cansu Kücükköse, Asli Aras Taskin, Adinarayana Marada, et al.
Cell Communication and Signaling : CCS
|
June 14, 2023
Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase
Lino Rohrer, Corinna Spohr, Carina Beha, et al.
Cell Communication and Signaling : CCS
|
December 21, 2021
Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts
Eyleen Corrales, Ella Levit-Zerdoun, Patrick Metzger, et al.
Cell Communication and Signaling : CCS
|
February 26, 2016
Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Sebastian Halbach, Zehan Hu, Christine Gretzmeier, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Oncogene
|
August 15, 2020
BRAF<sup>V600E</sup> drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Nadine Reischmann, Geoffroy Andrieux, Ricarda Griffin, et al.
Oncotarget
|
January 23, 2016
Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
Raphaela Fritsche-Guenther, Franziska Witzel, Stefan Kempa, et al.
European Journal of Immunology
|
December 8, 2004
Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors
Susana Minguet, Michael Huber, Lisa Rosenkranz, et al.
Molecular Biology of the Cell
|
December 18, 2012
PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway
Christine Kienzle, Stephan A Eisler, Julien Villeneuve, et al.
International Journal of Cancer
|
March 15, 2026
Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics
Viktoria Zieger, Ellen Woehr, Jasmin Traichel, et al.
Oncotarget
|
May 15, 2015
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
Kerstin Mock, Bogdan-Tiberius Preca, Tilman Brummer, et al.
The FEBS Journal
|
June 4, 2020
Functional coupling of presequence processing and degradation in human mitochondria
Cansu Kücükköse, Asli Aras Taskin, Adinarayana Marada, et al.
Cell Communication and Signaling : CCS
|
June 14, 2023
Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase
Lino Rohrer, Corinna Spohr, Carina Beha, et al.
Cell Communication and Signaling : CCS
|
December 21, 2021
Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts
Eyleen Corrales, Ella Levit-Zerdoun, Patrick Metzger, et al.
Cell Communication and Signaling : CCS
|
February 26, 2016
Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Sebastian Halbach, Zehan Hu, Christine Gretzmeier, et al.
Page
of 12